Johnson & Johnson Careers
Director of Program Management
Raritan, New Jersey; New Brunswick, New Jersey; Spring House, Pennsylvania
Requisition ID: 8477190627
The DPM is accountable to both the Head, CSP, and LCI leadership for initiating, planning, executing, controlling, reporting, and terminating the integrated, end-to-end evidence generation and commercialization strategy plans as approved in alignment with LCI strategies and projects.
As a core member of the Lung Interventions Steering Team, the DPM provides program management and cross-functional operational leadership for the development of diagnostic and therapeutic solutions across medical device, pharmaceutical and consumer products in a global, matrix organization in alignment with the LCI, from discovery through to life-cycle management. Individuals in this role will also provide matrixed leadership and direction to other staff within the LCI as appropriate.
The DPM will be a seasoned leader who can effectively navigate the complexities of J&J cross-sector solution development activities and compliantly drive towards bringing these new solutions to patients. A strong understanding of working across the matrix will be a critical success factor for this individual.
DPMs are guided in all matters by our J&J Credo values and our Leadership Imperatives.
Primary Duties of DPM Role:
Director of Program Management (DPM), LCI
- Establish operational strategy with the Lung Interventions Steering Team in partnership with the Head, CSP, with goals and objectives that are aligned with organizational objectives. Accountable for alignment with the overall LCI portfolio strategy. Contribute to and coordinate operational strategy updates over time. Provide context and history to new team members/stakeholders. Mentor colleagues in team best practices.
- Lead team to translate strategy on specific LCI projects into an integrated, executable plan. This includes scenario planning, stage gate approvals and setting priorities, and optimizing plans through constructive challenge and continuous dialog with the different functions to ensure all activities are aligned with team goals and objectives.
- Drive teams, particularly the Lung Interventions Steering Team, to meet or exceed those goals by providing superior global cross-functional operational leadership and management in a matrix organization. This includes scenario planning, resource planning, risk management, issue identification and mitigation, problem-solving, contingency planning, action-item follow-up, decision-support and decision-making. Work with standard budgeting and forecasting models to address specific project needs in collaboration with team partners; identify trade-off options and novel approaches to exploring technical risk and accelerating asset development.
- Manage team information, documentation, and communications to ensure timely and accurate dissemination of strategy and operational status throughout the Company and between co-development partners and/or other external partners (as required). Ensure documentation of team meetings, key decisions, action items and cross functional communication.
- Employ and help shape reporting processes and tools established by the LCI and best practices from across J&J. Assist with portfolio analyses on request.
- Partner with key stakeholders including Finance to support Continuous Forecast and Business Plan cycles.
- Partner with cross functional leads (e.g., Clinical, Engineering, Commercial, Statistics, Clinical Pharmacology, Biomarkers, Clinical Supplies, Global Medical Safety, Finance, Regulatory, etc.) across Medical Device, Janssen and Consumer at the program level to assure end to end program oversight; and to identify and mitigate risks and issues in order to maintain quality, timelines, resources and budget.
- Partner with cross functional leads to provide planning and oversight in the design, development and submission of key clinical documents including protocol, study reports and appendices.
- Take a lead role in ensuring cross-functional readiness for stage gate reviews and governance reviews and decisions, including for Development Committee, LCI LT and GEI LT meetings.
- Work cross-functionally to drive the planning and preparation of clinical and regulatory documents required for successful Health Authority submissions, and clinically-related external committees and meetings such as Advisory Boards.
- Manage and lead relevant subteams in a manner that fosters and maintains a high-performance team culture.
- If applicable, on external partnerships, work within the Joint Development Team or equivalent to manage and align cross company research activities and objectives.
- As needed, represent the Company at large. This may include governance meetings, external partnerships, and external meetings such as Health Authority Meetings, Advisory Meetings, Scientific Conferences, or Investigator Meetings.
Individual leader. Create and manage a high performing team culture, for example:
- Motivate colleagues through personal example, and dedication to team goals. Inspire confidence and build group trust. Understand strengths and motivators of team members. Use emotional intelligence to spot signals others miss. Provide positive and constructive feedback in the moment.
- Demonstrate ability to resolve conflict and influence teams without formal authority. Keep group focused on strategy and goal execution despite complexity, controversy, or conflict. Build bridges between organizations; turn adversity into opportunities for change and growth.
- Frame and translate organizational messages into meaningful information and insights for the team.
- Identify and manage stakeholder and team needs and expectations.
- Develop networks beyond scope of work to leverage connections that foster individual and team growth.
- Guided in all matters by our J&J Credo values and our J&J Leadership Performance standards.
Licensing and Acquisition (L&A)
- As required, and in collaboration with the LCI, Business Development and the Due Diligence team, generate and refine program development plan and resource modeling for early stage Due Diligence, governance review, and final deal model at appropriate points during the L&A process.
- A minimum of a Bachelor’s degree is required.
- Post-graduate degree in life sciences, engineering, or business management preferred.
- A minimum of 8-10 years of experience in project management, team leadership, and/or functional line management, plus successful performance on a standard priority project as a DPM (or equivalent experience in a similar role in other departments or companies) Is required
Plus any of the following (and/or):
1)Management of two or more compound stage gate decisions (e.g., NME Declaration, Full Development Decision, etc.), where the compound was advanced or terminated on technical, financial or commercial grounds
2) Management of a large program and/or several concurrent smaller programs (e.g., early stage or line extensions) with increasing levels of complexity and functional/external interactions.
- Personal contribution to, or leadership of the successful completion of two or more initiatives that resulted in demonstrable improvement in the quality or efficiency of Company processes, and/or that led to new capabilities within R&D or Pharma or Medical device is required
- Project management of one or more external innovation, partnership, or merger & acquisition initiatives, is required.
- Repeated demonstration of the ability to resolve conflict, influence teams, and build relationships in meeting organizational objectives without formal authority, required.
- This role can be based in either Raritan, New Brunswick, NJ, or Spring House, PA, with approx. 20% travel to other J&J sites expected is required
Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
United States-New Jersey-Raritan-
North America-United States-New Jersey-New Brunswick, North America-United States-Pennsylvania-Spring House
Janssen Research & Development, LLC. (6084)